As of January 22, 2025, Design Therapeutics (DSGN) has a market cap of $0.29 billion USD. According to our data, Design Therapeutics is ranked No.6734 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.29 B |
-16.05%
|
Dec 31, 2024 | $0.35 B |
132.83%
|
Dec 29, 2023 | $0.15 B |
-74.17%
|
Dec 30, 2022 | $0.58 B |
-52.08%
|
Dec 31, 2021 | $1.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Market Cap | = | DSGN Stock Price | * | DSGN Shares Outstanding |
= | $5.18 | * | 56.62 M | |
= | $0.29 B |